Compare NPT & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPT | CTSO |
|---|---|---|
| Founded | 2011 | 1997 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.7M | 26.5M |
| IPO Year | N/A | 2008 |
| Metric | NPT | CTSO |
|---|---|---|
| Price | $2.31 | $0.42 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | ★ 7.5M | 212.6K |
| Earning Date | 05-23-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $22,503,908.00 |
| Revenue This Year | N/A | $10.34 |
| Revenue Next Year | N/A | $22.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 48.53 |
| 52 Week Low | $1.14 | $0.37 |
| 52 Week High | $22.38 | $1.23 |
| Indicator | NPT | CTSO |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | 41.86 |
| Support Level | $1.19 | $0.37 |
| Resistance Level | $6.15 | $0.72 |
| Average True Range (ATR) | 1.18 | 0.06 |
| MACD | 0.12 | 0.00 |
| Stochastic Oscillator | 9.00 | 21.63 |
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.